It was hypothesized that a higher ejaculation frequency can protect against prostate cancer development or alternatively vasodilation induced by PDE5 inhibition may counteract hypoxia and thereby thwart the emergence of more aggressive cancer phenotypes [222–224]. This evidence concerns the gene PDE5A and prostate cancer.